Peptide number | Predicted epitope | Amino acid number | IC50 nM | HLA restriction | HLA supertype | Epitope number |
---|---|---|---|---|---|---|
1 | LLSAFEFTYMINF GR | 13-21 | 5 | B*1801 | B44 | E1 |
2 | QNSDVYRPINEH REH | 35-44 | 14991 | B*4402 | B44 | E2 |
3 | INEHREHPKEYEYPL | 47-55 | 18 | B*0801 | B08 | E3 |
4 | REHPKEYEYPL HQEH | Â | Â | Â | Â | Â |
5 | KEYEYPLHQEH TYQQ | 51-59 | 39 | B*1801 | B44 | E4 |
6 | NQYLKDGGFAF PTE | 175-183 | 142 | B*0801 | B08 | E5 |
7 | LMSPMTLDEMRHFYK | 194-202 | 17 | A*0101 | A01 | E6 |
8 | MTLDEMRHFYK DNKY | Â | Â | Â | Â | Â |
9 | EMRHFYKDNKY VKNL | 198-207 | 4742 | A*0101 | A01 | E7 |
10 | EDIPHVNEFPAIDLF | 327-335 | 7 | B*1801 | B44 | E8 |
11 | HVNEFPAIDLF ECNK | Â | Â | Â | Â | Â |
12 | CNKLVFELSA DQPK | 339-346 | 5708 | A*0201 | A02 | E9 |
13 | FKADRYKSHGKGY NW | 389-397 | 201 | A*3002 | A01 | E10 |
14 | ETQKCEIFNV KPCL | 405-414 | 142 | A*6802 | A02 | E11 |
 | ETQKCEIFNV KPCL | 406-414 | 919 | A*0201 | A02 | E12 |
15 | CEIFNVKPTCL INNS | 410-419 | 617 | A*6802 | A02 | E13 |
16 | TSNNEVVVKEEY DE | 520-528 | 15 | B*1801 | B44 | E14 |